Serum concentration of the cross-linked carboxyterminal telopeptide of type I collagen (ICTP) is a useful prognostic indicator in multiple myeloma.

por Elomaa, I., Virkkunen, P., Risteli, L., Risteli, J.
Publicado 1992

Measurement of growth rate of lung metastases in 21 patients with bone or soft-tissue sarcoma.

por Blomqvist, C., Wiklund, T., Tarkkanen, M., Elomaa, I., Virolainen, M.
Publicado 1993

Haematological toxicity: a marker of adjuvant chemotherapy efficacy in stage II and III breast cancer.

por Saarto, T., Blomqvist, C., Rissanen, P., Auvinen, A., Elomaa, I.
Publicado 1997

Aminoterminal propeptide of type I procollagen (PINP) correlates to bone loss and predicts the efficacy of antiresorptive therapy in pre- and post-menopausal non-metastatic breast...

por Saarto, T., Blomqvist, C., Risteli, J., Risteli, L., Sarna, S., Elomaa, I.
Publicado 1998

Clodronate improves bone mineral density in post-menopausal breast cancer patients treated with adjuvant antioestrogens.

por Saarto, T., Blomqvist, C., Välimäki, M., Mäkelä, P., Sarna, S., Elomaa, I.
Publicado 1997

Demonstration of increased collagen synthesis in irradiated human skin in vivo.

por Autio, P., Saarto, T., Tenhunen, M., Elomaa, I., Risteli, J., Lahtinen, T.
Publicado 1998

Raltitrexed treatment promotes systemic inflammatory reaction in patients with colorectal carcinoma

por Österlund, P, Orpana, A, Elomaa, I, Repo, H, Joensuu, H
Publicado 2002

Tamoxifen treatment reverses the adverse effects of chemotherapy-induced ovarian failure on serum lipids

por Vehmanen, L, Saarto, T, Blomqvist, C, Taskinen, M-R, Elomaa, I
Publicado 2004

Type III collagen metabolism in soft tissue sarcomas.

por Wiklund, T. A., Elomaa, I., Blomqvist, C. P., Risteli, L., Risteli, J.
Publicado 1992

Type I collagen degradation product (ICTP) gives information about the nature of bone metastases and has prognostic value in prostate cancer.

por Kylmälä, T., Tammela, T. L., Risteli, L., Risteli, J., Kontturi, M., Elomaa, I.
Publicado 1995

Type I and type III collagen metabolites in adult osteosarcoma patients.

por Wiklund, T., Blomqvist, C., Risteli, L., Risteli, J., Karaharju, E., Elomaa, I.
Publicado 1996

Markers of type I collagen degradation and synthesis in the monitoring of treatment response in bone metastases from breast carcinoma.

por Blomqvist, C., Risteli, L., Risteli, J., Virkkunen, P., Sarna, S., Elomaa, I.
Publicado 1996

The effect of clodronate and antioestrogens on bone loss associated with oestrogen withdrawal in postmenopausal women with breast cancer

por Saarto, T, Vehmanen, L, Elomaa, I, Välimäki, M, Mäkelä, P, Blomqvist, C
Publicado 2001

The combination of radiotherapy, adjuvant chemotherapy (cyclophosphamide-doxorubicin-ftorafur) and tamoxifen in stage II breast cancer. Long-term follow-up results of a randomised...

por Blomqvist, C., Tiusanen, K., Elomaa, I., Rissanen, P., Hietanen, T., Heinonen, E., Gröhn, P.
Publicado 1992

No evidence of microsatellite instability in bone tumours.

por Tarkkanen, M., Aaltonen, L. A., Böhling, T., Kivioja, A., Karaharju, E., Elomaa, I., Knuutila, S.
Publicado 1996

Concomitant i.v. and oral clodronate in the relief of bone pain--a double-blind placebo-controlled study in patients with prostate cancer.

por Kylmälä, T., Taube, T., Tammela, T. L., Risteli, L., Risteli, J., Elomaa, I.
Publicado 1997

Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study

por Österlund, P, Ruotsalainen, T, Korpela, R, Saxelin, M, Ollus, A, Valta, P, Kouri, M, Elomaa, I, Joensuu, H
Publicado 2007

Recurrent gains of 1q, 8 and 12 in the Ewing family of tumours by comparative genomic hybridization.

por Armengol, G., Tarkkanen, M., Virolainen, M., Forus, A., Valle, J., Böhling, T., Asko-Seljavaara, S., Blomqvist, C., Elomaa, I., Karaharju, E., Kivioja, A. H., Siimes, M. A., Tukiainen, E., Caballín, M. R., Myklebost, O., Knuutila, S.
Publicado 1997